Jatin Rao
27 comments
Recent Discussions
Citi advises investors to consider selling their shares in PNB, with a target price of ₹115 per share, due to the bank's solid liquidity and steady growth as indicated by its loan-to-deposit ratio of 73.7%. Investors may want to review their holdings in light of Citi's recommendation.
RPSG Ventures Ltd has secured a strong credit rating of IND A (Stable) and IND A2 for its 11,550 million rupee bank loans. This rating reflects the company's robust financial health, stable income stream, and backing from its parent group, despite providing financial support to subsidiaries through debt.
Analysts suggest investing in Adani Power, Titan, Cummins India, Mankind Pharmaceuticals, and Arvind Ltd, due to their positive technical trends and sectoral performance. Expected price levels for these stocks are Rs 170 (Adani Power), Rs 4,180 (Titan), Rs 4,820 (Cummins India), Rs 2,250 (Mankind Pharma), and Rs 430 (Arvind Ltd).
SEBI's proposal for open market buybacks could bolster shareholder confidence during market volatility, as it provides companies with the flexibility to use excess cash and maintain their stock prices. Notably, Infosys, GHCL, eClerx, and Bajaj Consumer have collectively invested over ₹20,000 crore in buybacks for FY25-26, indicating their faith in the companies' inherent worth. (The Hindu Business Line)
Marksans Pharma experienced a 7.9% surge in shares due to USFDA approval for a generic version of Tessalon (Benzonatate Capsules), previously owned by Pfizer. The company's Q3FY26 net profit increased significantly to ₹11,320.2 crore, with revenue growth of 10.6% YoY, attributed to strong execution and favorable market conditions.
Krishana Phoschem shares surge by 4.9% due to a 50% expansion of its DAP and NPK plant capacity to 4.95 lakh tonnes. This increase is attributed to a new Rs. 142 Crore project that includes an additional sulphuric acid line, which may help in reducing India's fertilizer imports.
Karur Vysya Bank experienced a significant 12% increase last week, hinting at a potential trend reversal due to a bullish engulfing pattern. With the target set at ₹375, investors may consider purchasing now and aiming for accumulation around ₹280. However, it's crucial to keep a stop-loss at ₹250, given the broader market's sharp decline.